The HEADWIND Study - Part 3

NCT05183191 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
11
Enrollment
OTHER
Sponsor class

Conditions

Interventions

Sponsor

Insel Gruppe AG, University Hospital Bern

Collaborators